Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial sulfhydryl-containing proteins are a diverse group of enzymes and structural components that utilize the thiol (-SH) group of cysteine residues for catalytic activity or structural stability (StatPearls, 2023). These proteins are critical for bacterial survival, participating in essential processes such as cellular respiration, glycolysis, and the maintenance of redox balance (PubMed, PMID: 11096079). Antimicrobial agents, particularly heavy metals like silver and mercury, exert their bactericidal effects by binding to these sulfhydryl groups, forming stable mercaptides that lead to protein denaturation and the loss of enzymatic function (NIH, 2022). This broad-spectrum mechanism of action is utilized by various topical antiseptics and disinfectants to treat or prevent bacterial infections (PubChem). However, the non-specific nature of this interaction means that these drugs can also affect host proteins, leading to potential toxicity and limiting their use primarily to topical or external applications (Wikipedia, 2024). Resistance to these agents is relatively rare compared to site-specific antibiotics because they target multiple essential proteins simultaneously. Despite their potential for toxicity, compounds targeting these groups remain important in clinical settings for wound care and as preservatives in pharmaceutical formulations.
Binding of heavy metal ions or electrophilic agents to the sulfur atom of the sulfhydryl (thiol) group, leading to the formation of stable mercaptides, protein denaturation, and the inactivation of essential bacterial enzymes (PubMed, PMID: 23017170).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial sulfhydryl-containing proteins.